Ju F, Luo Y, Lin C, et al. Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade. The gene discussed is HAVCR2; the disease is neoplasm.